BPH Development, Progression Linked to Sleep Problems
Findings emerged from an analysis of data from 2588 men who participated in the REDUCE trial.
Findings emerged from an analysis of data from 2588 men who participated in the REDUCE trial.
In a single-center study, 24% of patients crossed over to treatment and 95% of patients were alive after 5 years of follow-up.
In a study, 2-year survival rates were 14.4% for whites compared with 6.5% for blacks.
Likelihood of stone passage in patients on medical expulsive therapy is based on variables such as stone size and location and white blood cell count.
Finding could explain the association between obesity and diabetes and the development of kidney stones.